Gastroparesis Outcome Longitudinal Database Enrolled Numerically

ConditionGastroparesis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Louisville

About this trial

GOLDEN is a longitudinal database of patients with the symptoms (Sx) of gastroparesis (Gp) who were seen and recorded at the University of Louisville from 2012 and is ongoing. Patients are enrolled and followed by sequential numbers and may include legacy patients seen at other centers by some of the same team and who are reported as part of the series. Outcome relate to patients Sx, survival, quality of life and other measures as detailed below, over time. The study tracks patients regardless of treatment but specifically focuses on GI Neuromodulation (gastric electrical stimulation - GES), Immunotherapy (IVIG), and Pyloric therapies (pyloroplasty, endoscopic). If treatments were administered GOLDEN allows for examination and stratification of outcome by groups both at baseline and at follow up.

Eligibility criteria

Qualifiers

Patients with the symptoms (Sx) of drug refractory gastroparesis

Disordered nutrition by standardized assessment

Ability to assess current symptom status

Ability to measure other medical conditions

Disqualifiers

None

Trial design

Treatments tested in this trial

  • GI Neuromodulation
  • Immunotherapy
  • Pyloric Therapies

Treatment groups

3,000 Participants
are divided into 1 treatment group

Sponsors and collaborators